首页> 外文期刊>Journal of cardiovascular pharmacology and therapeutics >Bacteremia during quinsy and elective tonsillectomy: An evaluation of antibiotic prophylaxis recommendations for patients undergoing tonsillectomy
【24h】

Bacteremia during quinsy and elective tonsillectomy: An evaluation of antibiotic prophylaxis recommendations for patients undergoing tonsillectomy

机译:昆西和选择性扁桃体切除术期间的细菌血症:对扁桃体切除术患者的抗生素预防建议的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Bacteremia during elective tonsillectomy is well recognized, whereas bacteremia during quinsy tonsillectomy has never been studied. The aim of the present study was to explore the incidence of bacteremia during elective and quinsy tonsillectomy in order to evaluate the antibiotic prophylaxis recommendations to patients at high risk of infective endocarditis who are undergoing tonsillectomy. Methods: A prospective study was conducted on 80 patients undergoing elective tonsillectomy and 36 patients undergoing acute tonsillectomy due to peritonsillar abscess. Blood cultures, tonsillar swabs, core tissue, and pus aspirates were analyzed by standard microbiological techniques. Results: Bacteremia was detected in 73% of patients during elective tonsillectomy compared to 56% during quinsy tonsillectomy (P =.089, Fishers exact test). Significantly more blood culture bottles were positive for each isolate obtained from elective tonsillectomy cases compared to quinsy tonsillectomy cases (P < .001, Spearman rank correlation). In all, 59% and 42% of electively and acutely tonsillectomized patients, respectively, had bacteremia with microorganisms that are predominant in bacterial endocarditis. Ninety-three percent of the isolated strains were sensitive to amoxicillin, and all were sensitive to amoxicillin with clavulanic acid. Discussion: Our results challenge the distinction made by the European Society of Cardiology between elective and quinsy tonsillectomy, with regard to antibiotic prophylaxis recommendation only to patients undergoing procedures to treat an established infection. To provide full empiric coverage, including coverage for Staphylococcus aureus, we advocate the use of amoxicillin with clavulanic acid in patients at high risk of infective endocarditis.
机译:目的:选择性扁桃体切除术中的细菌血症已得到公认,而昆西扁桃体切除术中的菌血症从未研究过。本研究的目的是探讨选择性扁桃体切除术和昆西扁桃体切除术中菌血症的发生率,以评估对感染性心内膜炎高风险患者进行扁桃体切除术的抗生素预防建议。方法:对80例因扁桃体周围脓肿而行选择性扁桃体切除术和36例急性扁桃体切除术患者进行了前瞻性研究。通过标准微生物学技术分析血液培养物,扁桃体拭子,核心组织和脓液。结果:选择性扁桃体切除术中73%的患者检测到细菌血症,而昆西扁桃体切除术中56%的患者检测到细菌血症(P = .089,Fishers精确检验)。从选择性扁桃体切除术病例中获得的每个分离株,与昆西扁桃体切除术病例相比,显着更多的血液培养瓶呈阳性(P <.001,Spearman等级相关性)。在选择性和急性扁桃体切除术的患者中,分别有59%和42%的人患有细菌性心内膜炎的主要菌群发生了菌血症。 93%的分离菌株对阿莫西林敏感,而所有菌株均对克拉维酸对阿莫西林敏感。讨论:我们的研究结果挑战了欧洲心脏病学会在选择性扁桃体切除术和昆西扁桃体切除术之间的区别,即仅向接受过确诊感染治疗的患者推荐抗生素预防。为了提供全面的经验覆盖,包括金黄色葡萄球菌覆盖,我们提倡将阿莫西林与克拉维酸一起用于感染性心内膜炎高风险患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号